ORAI2 and early-onset autosomal dominant Alzheimer disease: Of note, another study showed, in a cell model of Alzheimer’s disease, that downregulation of Orai2 increases SOCE and decreases amyloid-beta accumulation, which suggests a potential benefit for Orai2 knockdown in Alzheimer’s disease (Scremin et al., 2020).